Burdash N M, Smith K A, Welborn A L
Eur J Clin Microbiol. 1982 Jun;1(3):131-3. doi: 10.1007/BF02019611.
The ability of two commercial kits to detect Haemophilus influenzae type b antigen in cerebrospinal fluid was evaluated. Results obtained by Bactogen, a latex agglutination test, and Phadebact, a coagglutination test, were compared to counterimmunoelectrophoresis, Gram stain and culture results. One hundred and seven specimens of cerebrospinal fluid were tested. Thirty were found to contain bacteria, 20 of which were Haemophilus influenzae type b. All 20 were positive by Bactogen and Phadebact testing, 19 were culture positive, 18 were positive by counterimmunoelectrophoresis and 15 had gram-negative bacilli seen on Gram stain. The culture negative specimen contained microscopically visible gram-negative bacilli and was from a patient on antimicrobial therapy who was previously Haemophilus influenzae type b culture positive. No false positives from other genera or the 77 culture negative specimens occurred with Phadebact, Bactogen or counterimmunoelectrophoresis.
对两种商用试剂盒检测脑脊液中 b 型流感嗜血杆菌抗原的能力进行了评估。将乳胶凝集试验 Bactogen 和协同凝集试验 Phadebact 的结果与对流免疫电泳、革兰氏染色及培养结果进行了比较。对 107 份脑脊液标本进行了检测。发现 30 份标本含有细菌,其中 20 份为 b 型流感嗜血杆菌。Bactogen 和 Phadebact 检测的所有 20 份标本均呈阳性,19 份培养阳性,18 份对流免疫电泳阳性,15 份革兰氏染色可见革兰氏阴性杆菌。培养阴性的标本在显微镜下可见革兰氏阴性杆菌,来自一名接受抗菌治疗的患者,该患者之前 b 型流感嗜血杆菌培养呈阳性。Phadebact、Bactogen 或对流免疫电泳未出现来自其他菌属的假阳性或 77 份培养阴性标本的假阳性。